Evidence map›Paper›PMID 22262158›Full record

ArticleObesity (Silver Spring, Md.)2012

Early alterations of the immune transcriptome in cultured progenitor cells from obese African-American women.

Priscilla E Pemu, Leonard Anderson, Beatrice E Gee, Elizabeth O Ofili, Sujoy Ghosh

Open access · bronzeAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Priscilla E PemuClinical Research Center, Morehouse School of Medicine, Atlanta, GA, USA.
Leonard Anderson
Beatrice E Gee
Elizabeth O Ofili
Sujoy Ghosh
Morehouse School of Medicine · USNorth Carolina Central University · US

Funding

Morehouse School of Medicine Center of Excellence Research Endowment ProgramS21MD000101 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI MONTGOMERY-RICE, VALERIE C. · 2001 to 2015
$74.3M
TRANSCRIPTION FACTORS AND PROSTATE CANCERG12RR003034 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI LIU, DONG · 1986 to 2011
$32.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Research Desogn and Biostatistics CoreU54MD007588 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI MONTGOMERY-RICE, VALERIE C. · 2012 to 2018
$24.8M
ROLES OF INFLAMMATION AND ANDROGEN METABOLISM IN PROSTATE CANCER DISPARITYP20MD000175 · NIMHD · NORTH CAROLINA CENTRAL UNIVERSITY · PI KIMBRO, KEVIN SEAN, POINTER, MILDRED AUDREY · 2002 to 2016
$15.6M
WARCEFU54RR026137 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI CONERLY HOLLIDAY, RHONDA C · 2009 to 2011
$14.6M
WARCEFP20RR011104 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI OFILI, ELIZABETH O. · 1995 to 2009
$14.5M
Morehouse School of Medicine Center of Clinical Research ExcellenceU54RR022814 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI GIBBONS, GARY H · 2005 to 2009
$5.8M
Renewal Application for Clinical Research Education and Career Development (CRECDR25RR017694 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI OFILI, ELIZABETH O. · 2002 to 2011
$5.5M
MSM Cardiovascular Center of ExcellenceR25HL003676 · NHLBI · MOREHOUSE SCHOOL OF MEDICINE · PI GIBBONS, GARY H · 2005 to 2009
$3.7M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalKL2TR000455 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$2.9M
American Heart Association-American Stroke Association 10SDG4230068NCATS NIH HHS KL2 TR000455NCATS NIH HHS UL1 TR000454NCRR NIH HHS 2R25RR017694-06A1NCRR NIH HHS 5P20RR11104NCRR NIH HHS 5U54RR022814NCRR NIH HHS G12 RR003034NCRR NIH HHS G12-RR03034NCRR NIH HHS P20 RR011104NCRR NIH HHS R25 RR017694NCRR NIH HHS U54 RR022814NCRR NIH HHS U54 RR026137NCRR NIH HHS UL1 RR025008NHLBI NIH HHS 5R25HL003676NHLBI NIH HHS 5R25HL059868-10NHLBI NIH HHS R25 HL003676NHLBI NIH HHS R25 HL059868NHLBI NIH HHS U01 HL084891NHLBI NIH HHS UO1HL084891NIDDK NIH HHS 1R21DK088319-01NIDDK NIH HHS R21 DK088319NIMHD NIH HHS P20 MD000175NIMHD NIH HHS P20MD000175-09NIMHD NIH HHS S21 MD000101NIMHD NIH HHS U54 MD007588
6 · The paper itself

Abstract

Progenitor cells (PCs) are key components of vasculogenic remodeling and hematopoietic development. Decreases in the number and function of angiogenic progenitors have been observed in coronary artery disease, hypertension, and diabetic vasculopathy. Several recent studies have also demonstrated a close relationship between increased visceral fat and cardiovascular disease, implying an association between obesity and vascular dysfunction. However, very little is known about the role of PCs in obesity. We generated whole genome expression profiles of cultured PCs from 18 obese and 6 lean African-American women on Agilent microarrays and analyzed the data through bioinformatic pathway analysis using multiple databases and analytic tools. False-discovery rates (FDR) were calculated to assess statistical significance while controlling for multiple testing. We identified 1,145 upregulated and 2,257 downregulated genes associated with obesity (1.5-fold or greater absolute fold-change). Pathway analysis further identified a statistically significant downregulation of immune-response pathways in the obese subjects, including T-cell receptor signaling, natural killer cell signaling, and chemokine-signaling pathways (FDR <5%). Chemokine gene-expression patterns were consistent with an angiogenic-angiostatic imbalance and a downregulation of CXCR3 receptor-mediated signaling in the PCs from obese subjects. Overall, these findings reveal a novel transcriptional signature in cultured PCs from obese African-American women and further suggest that obesity-associated immune-compromise may originate much earlier in cellular development than currently appreciated. Clinically, this may translate into a lengthier period of immune dysregulation in obese subjects exposing them to greater risks of infection and other morbidities.

Indexed as

AdolescentAdultBlack or African AmericanCells, CulturedFemaleHumansIntra-Abdominal FatKiller Cells, NaturalLymphocyte ActivationMiddle AgedObesityReceptors, CXCR3Signal TransductionTranscriptomeYoung AdultCXCR3 protein, humanReceptors, CXCR3

Identifiers

PMID22262158
PMCPMC3611330
OpenAlexW2083183536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.